» Articles » PMID: 29078411

PELI1 Functions As a Dual Modulator of Necroptosis and Apoptosis by Regulating Ubiquitination of RIPK1 and MRNA Levels of C-FLIP

Overview
Specialty Science
Date 2017 Oct 29
PMID 29078411
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis and necroptosis are two distinct cell death mechanisms that may be activated in cells on stimulation by TNFα. It is still unclear, however, how apoptosis and necroptosis may be differentially regulated. Here we screened for E3 ubiquitin ligases that could mediate necroptosis. We found that deficiency of Pellino 1 (PELI1), an E3 ubiquitin ligase, blocked necroptosis. We show that PELI1 mediates K63 ubiquitination on K115 of RIPK1 in a kinase-dependent manner during necroptosis. Ubiquitination of RIPK1 by PELI1 promotes the formation of necrosome and execution of necroptosis. Although PELI1 is not directly involved in mediating the activation of RIPK1, it is indispensable for promoting the binding of activated RIPK1 with its downstream mediator RIPK3 to promote the activation of RIPK3 and MLKL. Inhibition of RIPK1 kinase activity blocks PELI1-mediated ubiquitination of RIPK1 in necroptosis. However, we show that PELI1 deficiency sensitizes cells to both RIPK1-dependent and RIPK1-independent apoptosis as a result of down-regulated expression of c-FLIP, an inhibitor of caspase-8. Finally, we show that mice are sensitized to TNFα-induced apoptosis. Thus, PELI1 is a key modulator of RIPK1 that differentially controls the activation of necroptosis and apoptosis.

Citing Articles

RIPK1 in necroptosis and recent progress in related pharmaceutics.

Yao K, Shi Z, Zhao F, Tan C, Zhang Y, Fan H Front Immunol. 2025; 16:1480027.

PMID: 40007541 PMC: 11850271. DOI: 10.3389/fimmu.2025.1480027.


Identification of PANoptosis-based signature for predicting the prognosis and immunotherapy response in AML.

Zhang L, Yu Y, Li G, Li J, Ma X, Ren J Heliyon. 2024; 10(22):e40267.

PMID: 39634422 PMC: 11616514. DOI: 10.1016/j.heliyon.2024.e40267.


RNA-Seq Reveals Transcriptome Changes Following Zika Virus Infection in Fetal Brains in Knockdown Mice.

Xie T, Chen Q, Li N, Zhang S, Zhu L, Bai S Viruses. 2024; 16(11).

PMID: 39599827 PMC: 11599063. DOI: 10.3390/v16111712.


Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.

Khan M, Huang X, Ye X, Zhang D, Wang B, Xu A Ann Med. 2024; 56(1):2405079.

PMID: 39387496 PMC: 11469424. DOI: 10.1080/07853890.2024.2405079.


Targeting necroptosis: a promising avenue for respiratory disease treatment.

Cao X, Tan J, Zheng R, Wang F, Zhou L, Yi J Cell Commun Signal. 2024; 22(1):418.

PMID: 39192326 PMC: 11350980. DOI: 10.1186/s12964-024-01804-6.


References
1.
Weinlich R, Oberst A, Beere H, Green D . Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2016; 18(2):127-136. DOI: 10.1038/nrm.2016.149. View

2.
Degterev A, Boyce M, Yuan J . A decade of caspases. Oncogene. 2003; 22(53):8543-67. DOI: 10.1038/sj.onc.1207107. View

3.
Caccamo A, Branca C, Piras I, Ferreira E, Huentelman M, Liang W . Necroptosis activation in Alzheimer's disease. Nat Neurosci. 2017; 20(9):1236-1246. DOI: 10.1038/nn.4608. View

4.
Murphy J, Czabotar P, Hildebrand J, Lucet I, Zhang J, Alvarez-Diaz S . The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013; 39(3):443-53. DOI: 10.1016/j.immuni.2013.06.018. View

5.
Newton K, Matsumoto M, Wertz I, Kirkpatrick D, Lill J, Tan J . Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell. 2008; 134(4):668-78. DOI: 10.1016/j.cell.2008.07.039. View